Bayer reported a loss of $165 million for the third quarter, blaming a weak global economy and the withdrawal of Baycol after it was linked to patient deaths.
(via LA Times)
Bayer reported a loss of $165 million for the third quarter, blaming a weak global economy and the withdrawal of Baycol after it was linked to patient deaths.
(via LA Times)
Comments on this entry are closed.